Mohammedbaqer Ali Al-Ghuraibawi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammedbaqer Ali Al-Ghuraibawi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Samer S. Hoz
Department of Neurosurgery, University of Cincinnati Medical Center, Cincinnati, Ohio, United States
6 shared publications - Ahmed Muthana
College of Medicine, University of Baghdad, Baghdad, Iraq
4 shared publications - Bandar Mohammed Alhadeethi
Department of Neurosurgery, University of Baghdad, Baghdad, Iraq
3 shared publications - Mayur Sharma
Department of Neurosurgery, University of Louisville, Kentucky, United States
3 shared publications - Hashim Talib Hashim
Department of Research, University of Warith Al-Anbiyaa, College of Medicine, Karbala, Iraq
2 shared publications - Mustafa Ismail
Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, United States
2 shared publications
Latest Publications
- Open Access
- 29 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 367
Orbito-cranial penetrating head injury by tear gas canister: A case report
Background: Orbito-cranial penetrating injuries caused by tear gas canisters (TGCs) are rare but devastating incidents. These injuries combine severe kinetic trauma with chemical irritation, resulting in complex neurosurgical emergencies that demand prompt multidisciplinary intervention. Case Description: This report describes a 27-year-old male who sustained a penetrating orbital injury from a TGC during a protest. The patient presented with a Glasgow Coma Scale (GCS) score of 9, a fractured skull, herniated brain tissue, and multiple intracranial hemorrhages. Emergency craniotomy was performed, including hematoma evacuation, removal of the canister and bone fragments, and reconstruction of the skull base. Despite initial stabilization, the patient’s condition deteriorated postoperatively, leading to sudden cardiac arrest on day three. Tear gas canisters, commonly used for riot control, can cause severe orbito-cranial injuries when deployed at high velocity. These injuries pose significant diagnostic and therapeutic challenges due to their combined mechanical and chemical effects. The case underscores the critical need for resources like intracranial pressure monitoring and advanced neurosurgical care in managing such injuries, especially in conflict zones. The orbito-cranial involvement highlights the vulnerability of the orbital region and its potential to result in fatal outcomes. Conclusion: Orbito-cranial injuries caused by TGCs represent a unique and severe subset of trauma requiring immediate and specialized intervention. This case emphasizes the need for improved safety protocols, systematic injury documentation, and enhanced neurosurgical infrastructure to effectively manage and improve outcome.
- 29 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 367
Open AccessOrbito-cranial penetrating head injury by tear gas canister: A case report
Background: Orbito-cranial penetrating injuries caused by tear gas canisters (TGCs) are rare but devastating incidents. These injuries combine severe kinetic trauma with chemical irritation, resulting in complex neurosurgical emergencies that demand prompt multidisciplinary intervention. Case Description: This report describes a 27-year-old male who sustained a penetrating orbital injury from a TGC during a protest. The patient presented with a Glasgow Coma Scale (GCS) score of 9, a fractured skull, herniated brain tissue, and multiple intracranial hemorrhages. Emergency craniotomy was performed, including hematoma evacuation, removal of the canister and bone fragments, and reconstruction of the skull base. Despite initial stabilization, the patient’s condition deteriorated postoperatively, leading to sudden cardiac arrest on day three. Tear gas canisters, commonly used for riot control, can cause severe orbito-cranial injuries when deployed at high velocity. These injuries pose significant diagnostic and therapeutic challenges due to their combined mechanical and chemical effects. The case underscores the critical need for resources like intracranial pressure monitoring and advanced neurosurgical care in managing such injuries, especially in conflict zones. The orbito-cranial involvement highlights the vulnerability of the orbital region and its potential to result in fatal outcomes. Conclusion: Orbito-cranial injuries caused by TGCs represent a unique and severe subset of trauma requiring immediate and specialized intervention. This case emphasizes the need for improved safety protocols, systematic injury documentation, and enhanced neurosurgical infrastructure to effectively manage and improve outcome.
- Open Access
- 29 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 366
Trochlear nerve palsy associated with intracranial aneurysms: Scoping review
Background: Trochlear nerve palsy (TNP) in patients with ruptured or unruptured intracranial aneurysms (IA) can result from the disease process or its treatment. We systematically reviewed the literature on TNP in patients with IA. Methods: PubMed, ScienceDirect, and Web of Science were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data extraction and quality assessment were performed according to pre-established guidelines. Results: Our review yielded 29 studies out of 273 retrieved articles. A total of 134 patients with TNP and IA were included in our study. The mean age was 55.35 years and females accounted for 78%. Among the TNP cases, 91% harbored aneurysms located in the internal carotid artery and posterior communicating artery, and 93% of these aneurysms were large to giant-sized aneurysms. Out of the total cases, the vast majority (96.2%) exhibited TNP at the time of their initial presentation. Only a small proportion (n = 5, 3.73%) developed TNP after the treatment of their aneurysms. For the multiplicity of cranial nerve involvement, 81 (60.4%) had cranial nerve palsies other than trochlear palsy, and the remaining 53 (39.5%) had isolated TNP. Finally, in terms of TNP outcome, the recovery rate from TNP was identified in 110 cases (85.2%), with a duration of resolution of n = 58, 89.2%). Conclusion: TNPs are correlated with IAs, and this correlation depends on the location and size of the aneurysms.
- 29 August 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 366
Open AccessTrochlear nerve palsy associated with intracranial aneurysms: Scoping review
Background: Trochlear nerve palsy (TNP) in patients with ruptured or unruptured intracranial aneurysms (IA) can result from the disease process or its treatment. We systematically reviewed the literature on TNP in patients with IA. Methods: PubMed, ScienceDirect, and Web of Science were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data extraction and quality assessment were performed according to pre-established guidelines. Results: Our review yielded 29 studies out of 273 retrieved articles. A total of 134 patients with TNP and IA were included in our study. The mean age was 55.35 years and females accounted for 78%. Among the TNP cases, 91% harbored aneurysms located in the internal carotid artery and posterior communicating artery, and 93% of these aneurysms were large to giant-sized aneurysms. Out of the total cases, the vast majority (96.2%) exhibited TNP at the time of their initial presentation. Only a small proportion (n = 5, 3.73%) developed TNP after the treatment of their aneurysms. For the multiplicity of cranial nerve involvement, 81 (60.4%) had cranial nerve palsies other than trochlear palsy, and the remaining 53 (39.5%) had isolated TNP. Finally, in terms of TNP outcome, the recovery rate from TNP was identified in 110 cases (85.2%), with a duration of resolution of n = 58, 89.2%). Conclusion: TNPs are correlated with IAs, and this correlation depends on the location and size of the aneurysms.
- RetractedOpen Access
- 25 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (30) , e43626
Asymptomatic young male with ectopia cordis interna: A rare case report
Rationale: Ectopia cordis interna is a rare congenital condition that occurs when the heart is found within the abdominal cavity. Patient concerns: A 22-year-old Iraqi male with a chest infection presented to the clinic with a chest infection, during which the anomaly was incidentally discovered. Diagnoses: Although there are no clear symptoms, the anomaly can lead to potential risks during any abdominal procedures. Interventions: The patient got a chest X-ray for his infection, which revealed the anomaly. Outcomes and lessons: The case highlights the importance of early detection of this condition through imaging modalities and the need for focused research into its long-term implications and management strategies.
- 25 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (30) , e43626
RetractedOpen AccessAsymptomatic young male with ectopia cordis interna: A rare case report
Rationale: Ectopia cordis interna is a rare congenital condition that occurs when the heart is found within the abdominal cavity. Patient concerns: A 22-year-old Iraqi male with a chest infection presented to the clinic with a chest infection, during which the anomaly was incidentally discovered. Diagnoses: Although there are no clear symptoms, the anomaly can lead to potential risks during any abdominal procedures. Interventions: The patient got a chest X-ray for his infection, which revealed the anomaly. Outcomes and lessons: The case highlights the importance of early detection of this condition through imaging modalities and the need for focused research into its long-term implications and management strategies.
- 7 July 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-12
Toripalimab in Esophageal Cancer: A Systematic Review and Meta-Analysis
Background Esophageal cancer (EC) remains a highly aggressive malignancy with a poor prognosis despite advancements in treatment. Toripalimab, a PD-1 inhibitor, has demonstrated the potential to improve clinical outcomes. This systematic review and meta-analysis assess the efficacy and safety of Toripalimab in EC. Methods Following PRISMA 2020 guidelines, we conducted a systematic review and meta-analysis, searching PubMed, Embase, Scopus, ScienceDirect, and Google Scholar up to January 2025. Eligible studies evaluated Toripalimab in esophageal cancer, including randomized controlled trials and non-randomized controlled trials. Primary outcomes included overall survival (OS), progression-free survival (PFS), and objective response rate (ORR), while safety outcomes assessed treatment-related adverse events. Data were synthesized using random-effects models, with heterogeneity evaluated via Cochrane’s Q and I2 statistics. Results The pooled analysis included six studies involving 678 patients. Toripalimab demonstrated promising efficacy, with a Complete Response (CR) rate of 33%, Partial Response (PR) rate of 36%, pathological complete response (pCR) rate of 30%, and major pathological response (MPR) rate of 46%. The R0 resection rate was 87%, while OS and PFS rates were reported at 78% and 50%, respectively. Anemia (56%), alopecia (54%), leukopenia (54%), and fatigue (30%) were the most frequently reported adverse effects. Other common adverse effects included nausea (29%), constipation (18%), and vomiting (20%). Conclusions Toripalimab demonstrates significant potential in treating esophageal cancer, with favorable response rates and survival outcomes. However, the high incidence of adverse effects highlights the need for supportive care and ongoing research. While based on limited sample sizes and single-arm studies that may introduce bias and affect generalizability in this review, we provide valuable preliminary insights into toripalimab’s potential, highlighting the need for larger randomized trials to build on these findings.
- 7 July 2025
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 56 (1) , 1-12
Toripalimab in Esophageal Cancer: A Systematic Review and Meta-Analysis
Background Esophageal cancer (EC) remains a highly aggressive malignancy with a poor prognosis despite advancements in treatment. Toripalimab, a PD-1 inhibitor, has demonstrated the potential to improve clinical outcomes. This systematic review and meta-analysis assess the efficacy and safety of Toripalimab in EC. Methods Following PRISMA 2020 guidelines, we conducted a systematic review and meta-analysis, searching PubMed, Embase, Scopus, ScienceDirect, and Google Scholar up to January 2025. Eligible studies evaluated Toripalimab in esophageal cancer, including randomized controlled trials and non-randomized controlled trials. Primary outcomes included overall survival (OS), progression-free survival (PFS), and objective response rate (ORR), while safety outcomes assessed treatment-related adverse events. Data were synthesized using random-effects models, with heterogeneity evaluated via Cochrane’s Q and I2 statistics. Results The pooled analysis included six studies involving 678 patients. Toripalimab demonstrated promising efficacy, with a Complete Response (CR) rate of 33%, Partial Response (PR) rate of 36%, pathological complete response (pCR) rate of 30%, and major pathological response (MPR) rate of 46%. The R0 resection rate was 87%, while OS and PFS rates were reported at 78% and 50%, respectively. Anemia (56%), alopecia (54%), leukopenia (54%), and fatigue (30%) were the most frequently reported adverse effects. Other common adverse effects included nausea (29%), constipation (18%), and vomiting (20%). Conclusions Toripalimab demonstrates significant potential in treating esophageal cancer, with favorable response rates and survival outcomes. However, the high incidence of adverse effects highlights the need for supportive care and ongoing research. While based on limited sample sizes and single-arm studies that may introduce bias and affect generalizability in this review, we provide valuable preliminary insights into toripalimab’s potential, highlighting the need for larger randomized trials to build on these findings.
- Open Access
- 30 May 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 209
Pseudoaneurysm development in extracranial-intracranial bypass surgery: Diagnostic challenges and surgical solutions
Background: Pseudoaneurysm formation at the anastomotic site of extracranial-intracranial (EC-IC) bypass surgery is a rare but potentially severe complication. Due to its unpredictable nature and associated risks, early detection and appropriate management are crucial. However, the rarity of this condition makes diagnosis and treatment challenging. This review explores the pathophysiology, risk factors, diagnostic strategies, and management options for pseudoaneurysms in EC-IC bypass procedures. Methods: A comprehensive literature search was conducted using the PubMed/MEDLINE database to identify studies related to pseudoaneurysm formation following EC-IC bypass surgery. The search algorithm applied was (((Pseudoaneurysm) AND (Extracranial) AND (Intracranial)) AND ((Bypass) OR (Revascularization) OR (Anastomosis))). Studies were included if they reported on pseudoaneurysm formation at the anastomotic site of EC-IC bypass procedures, including case reports, case series, retrospective studies, and reviews. Exclusion criteria encompassed studies focusing solely on nonanastomotic aneurysms, unrelated cerebrovascular procedures, or insufficient clinical data. Results: After applying the inclusion and exclusion criteria, a total of five studies were selected for detailed analysis. The extracted data included patient demographics, clinical presentation, imaging modalities used for diagnosis, treatment strategies, and postoperative outcomes. Conclusion: Pseudoaneurysms at EC-IC bypass sites pose significant diagnostic and therapeutic challenges. Given the potential for delayed complications, early detection, and individualized treatment strategies are essential. Long-term follow-up with serial imaging is necessary to monitor for recurrence and ensure optimal patient outcomes. Greater awareness and reporting of these cases will contribute to improved understanding and management of this rare complication.
- 30 May 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 209
Open AccessPseudoaneurysm development in extracranial-intracranial bypass surgery: Diagnostic challenges and surgical solutions
Background: Pseudoaneurysm formation at the anastomotic site of extracranial-intracranial (EC-IC) bypass surgery is a rare but potentially severe complication. Due to its unpredictable nature and associated risks, early detection and appropriate management are crucial. However, the rarity of this condition makes diagnosis and treatment challenging. This review explores the pathophysiology, risk factors, diagnostic strategies, and management options for pseudoaneurysms in EC-IC bypass procedures. Methods: A comprehensive literature search was conducted using the PubMed/MEDLINE database to identify studies related to pseudoaneurysm formation following EC-IC bypass surgery. The search algorithm applied was (((Pseudoaneurysm) AND (Extracranial) AND (Intracranial)) AND ((Bypass) OR (Revascularization) OR (Anastomosis))). Studies were included if they reported on pseudoaneurysm formation at the anastomotic site of EC-IC bypass procedures, including case reports, case series, retrospective studies, and reviews. Exclusion criteria encompassed studies focusing solely on nonanastomotic aneurysms, unrelated cerebrovascular procedures, or insufficient clinical data. Results: After applying the inclusion and exclusion criteria, a total of five studies were selected for detailed analysis. The extracted data included patient demographics, clinical presentation, imaging modalities used for diagnosis, treatment strategies, and postoperative outcomes. Conclusion: Pseudoaneurysms at EC-IC bypass sites pose significant diagnostic and therapeutic challenges. Given the potential for delayed complications, early detection, and individualized treatment strategies are essential. Long-term follow-up with serial imaging is necessary to monitor for recurrence and ensure optimal patient outcomes. Greater awareness and reporting of these cases will contribute to improved understanding and management of this rare complication.
- Open Access
- 28 March 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 104
Cerebral arteriovenous malformation calcifications: A systematic review, case series, and a proposed classification system
Background: Brain arteriovenous malformations (AVMs) are intracranial vascular lesions characterized by a nidus of vessels fed by an artery and drained by a vein, lacking intervening capillaries. Angiography remains the gold standard for a definitive diagnosis. There is a paucity in the literature regarding clinical presentation and management of patients with calcified cerebral AVM (cCAVM). This study aims to highlight the clinical presentation and management of patients with cCAVM and also to propose a classification of calcification patterns in cCAVMs based on brain computed tomography (CT) findings. Methods: A systematic review using PubMed, Scopus, and Web of Science was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify cases that illustrate cCAVM. A case series was also presented to supplement the current literature. Results: Twenty patients with cCAVM were included, with the male gender representing more than 50% of the patient population. Their age ranged from 11 to 69 years, with seizures being the most common presenting symptom. The frontal lobe was the most common location of AVMs, followed by the parietal lobe. Most (80%) of the calcifications were nidal, with the remaining being extranidal (20%). Conclusion: The CT scans of patients displayed significant variability due to the unique characteristics of each cCAVM. To address this diversity, a novel classification system was developed to provide a comprehensive framework for understanding cCAVMs based on their location, size, and extent.
- 28 March 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 104
Open AccessCerebral arteriovenous malformation calcifications: A systematic review, case series, and a proposed classification system
Background: Brain arteriovenous malformations (AVMs) are intracranial vascular lesions characterized by a nidus of vessels fed by an artery and drained by a vein, lacking intervening capillaries. Angiography remains the gold standard for a definitive diagnosis. There is a paucity in the literature regarding clinical presentation and management of patients with calcified cerebral AVM (cCAVM). This study aims to highlight the clinical presentation and management of patients with cCAVM and also to propose a classification of calcification patterns in cCAVMs based on brain computed tomography (CT) findings. Methods: A systematic review using PubMed, Scopus, and Web of Science was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify cases that illustrate cCAVM. A case series was also presented to supplement the current literature. Results: Twenty patients with cCAVM were included, with the male gender representing more than 50% of the patient population. Their age ranged from 11 to 69 years, with seizures being the most common presenting symptom. The frontal lobe was the most common location of AVMs, followed by the parietal lobe. Most (80%) of the calcifications were nidal, with the remaining being extranidal (20%). Conclusion: The CT scans of patients displayed significant variability due to the unique characteristics of each cCAVM. To address this diversity, a novel classification system was developed to provide a comprehensive framework for understanding cCAVMs based on their location, size, and extent.
- Open Access
- 17 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 15
Rituals and superstitions in neurosurgery
- 17 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 15
Open AccessRituals and superstitions in neurosurgery
- Open Access
- 1 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 415
Bilateral basal ganglia hemorrhage in a 2-year-old child
Basal ganglia hemorrhage is an intracerebral subtype of hemorrhage located in the caudate nucleus, putamen, globus pallidus, or adjacent structures such as the thalamus or internal capsule.
- 1 December 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 415
Open AccessBilateral basal ganglia hemorrhage in a 2-year-old child
Basal ganglia hemorrhage is an intracerebral subtype of hemorrhage located in the caudate nucleus, putamen, globus pallidus, or adjacent structures such as the thalamus or internal capsule.